NEPHRODI THERAPEUTICS, INC.

Profile

Company Names

NEPHRODI THERAPEUTICS, INC.

Addresses

2200 32ND AVE W, SEATTLE, WA 98199

1606 CHESTNUT STREET, UNIT 3, PHILADELPHIA, PA 19103

Phone Numbers

206-696-0546

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$3,600,018.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-06-11 
$2,000,000.00 
$3,999,999.00 
$1,999,999.00 
Equity 
1
2021-02-11 
$1,600,018.00 
$1,600,018.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED 
 
CALLORI 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  CATABASIS PHARMACEUTICALS INC   |  NEPHRODI THERAPEUTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  ZUCARA THERAPEUTICS INC.
CHRIS 
 
GARABEDIAN 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  VYOME THERAPEUTICS INC.   |  CEREVASC, INC.   |  NEPHRODI THERAPEUTICS, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  SHIFA BIOMEDICAL CORP   |  JUNO DIAGNOSTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  POLYCORE THERAPEUTICS, INC.   |  VIVOSENSE, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  MAREA THERAPEUTICS, INC.   |  ZUCARA THERAPEUTICS INC.
MICHAEL 
 
GRISSINGER 
DIRECTOR
AKARI THERAPEUTICS PLC   |  NEPHRODI THERAPEUTICS, INC.   |  APREA THERAPEUTICS, INC.
RACHAEL 
 
HAGAN 
EXECUTIVE OFFICER, DIRECTOR
NEPHRODI THERAPEUTICS, INC.
BIBHASH 
 
MUKHOPADHYAY 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  NEPHRODI THERAPEUTICS, INC.
JEFF 
M. 
SANDS, M.D. 
EXECUTIVE OFFICER
NEPHRODI THERAPEUTICS, INC.
DONNA 
 
SEE 
DIRECTOR
NEPHRODI THERAPEUTICS, INC.   |  THEON THERAPEUTICS, INC.   |  THEONYS, INC.   |  ORBITAL SIDEKICK, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-11 
2021-02-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#